Fayez Sarofim & Co’s Clorox CLX Stock Holding History

Fayez Sarofim & Co’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,419	Closed	-$393K	–	315
2024 Q4	$393K	Buy	+2,419	New	+$396K	﹤0.01%	249
2024 Q1	–	Sell	-2,623	Closed	-$402K	–	289
2023 Q4	$402K	Buy	2,623 +540	+26%	+$72K	﹤0.01%	230
2023 Q3	$273K	Hold	2,083	–	–	﹤0.01%	258
2023 Q2	$331K	Hold	2,083	–	–	﹤0.01%	232
2023 Q1	$330K	Hold	2,083	–	–	﹤0.01%	242
2022 Q4	$292K	Hold	2,083	–	–	﹤0.01%	246
2022 Q3	$267K	Hold	2,083	–	–	﹤0.01%	253
2022 Q2	$294K	Sell	2,083 -120	-5%	-$17.1K	﹤0.01%	264
2022 Q1	$306K	Hold	2,203	–	–	﹤0.01%	284
2021 Q4	$384K	Buy	2,203 +350	+19%	+$58.3K	﹤0.01%	277
2021 Q3	$307K	Sell	1,853 -118	-6%	-$20.3K	﹤0.01%	274
2021 Q2	$355K	Buy	1,971 +93	+5%	+$17K	﹤0.01%	272
2021 Q1	$362K	Buy	+1,878	New	+$362K	﹤0.01%	235
2020 Q4	–	Sell	-1,930	Closed	-$406K	–	274
2020 Q3	$406K	Buy	+1,930	New	+$430K	﹤0.01%	208

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fayez Sarofim & Co's CLX Position: Q1 2025 in Review

Fayez Sarofim & Co sold out of Clorox (CLX) in Q1 2025, closing a stake of 2,419 shares — an estimated $393K sold.

Fayez Sarofim & Co first reported a position in CLX in Q3 2020 and held it in 14 quarters. The position peaked at $406K in Q3 2020. 1,188 funds tracked by Wall St. Rank hold CLX as of Q1 2025.

Fayez Sarofim & Co reported no remaining Clorox position as of Q1 2025 after selling out during the quarter.
Fayez Sarofim & Co sold 2,419 Clorox shares in Q1 2025, an estimated $393K.
Fayez Sarofim & Co first reported a position in Clorox in Q3 2020 and held it in 14 quarters.
Fayez Sarofim & Co's Clorox position peaked at $406K in Q3 2020.
1,188 funds tracked by Wall St. Rank held Clorox as of Q1 2025.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.